Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples by Vogeser, Michael & Schelling, Gustav
Clin Chem Lab Med 2007;45(8):1023–1025  2007 by Walter de Gruyter • Berlin • New York. DOI 10.1515/CCLM.2007.197 2007/52
Article in press - uncorrected proof
Short Communication
Pitfalls in measuring the endocannabinoid 2-arachidonoyl
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Abstract
Background: The endocannabinoid 2-arachidonoyl
glycerol (2-AG) undergoes spontaneous isomerization
to biologically inactive 1-AG. This effect has not been
adequately addressed in previous studies that report-
ed 2-AG concentrations in biological samples.
Methods: Liquid chromatography tandem-mass
spectrometry (LC-MS/MS) was used for 1-AG and 2-
AG analyses.
Results: Identical collision-induced disintegration
spectra were found for 1-AG and 2-AG. For specific
detection of both compounds, which share a common
mass transition, baseline chromatographic separation
is mandatory, even when applying MS/MS techno-
logy with its generally high detection specificity.
When using standard chromatographic conditions
with the very short run times typically used in LC-MS/
MS methods, co-elution of 2-AG with 1-AG, which is
present in human serum, causes false 2-AG results.
Conclusions: Our data highlight that the analytical
specificity of MS/MS can be limited by interference
from isobaric isomers with identical disintegration
patterns. The specificity of this technology must be
carefully evaluated for each individual application.
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During recent years it has become evident that the
endocannabinoid system is part of fundamental reg-
ulatory mechanisms involved in numerous physiolog-
ical processes (1). While endocannabinoid CB1
receptors are abundant in the central nervous system,
CB2 receptors have been found primarily on periph-
eral immune and endothelial cells. Anandamide and
2-arachidonoyl glycerol (2-AG), both lipid mediators
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derived from membrane phospholipids or triglycer-
ides, are the most important ligands of these
receptors.
Most of our knowledge of the functional principles
of the endocannabinoid systems is based on experi-
ments in which endocannabinoids or analogues were
administered to animals or in which the effects of
blocking the enzymatic inactivation of endocannabi-
noids were investigated. Apparent concentrations of
2-AG in various sample materials have been reported
in a number of investigations that used liquid
chromatography (LC)-single-stage mass spectrometry
(MS) technology. However, an essential problem
regarding the measurement of 2-AG in biological
samples is that it undergoes rapid non-enzymatic
isomerization to 1-arachidonoyl glycerol (1-AG),
which is biologically inactive (2). It appears that this
issue has not been adequately addressed in the lit-
erature. This problem has either been ignored (3–6),
or 1-AG and 2-AG have been separated chromato-
graphically, but the concentrations of both com-
pounds have been added and a summed value has
been reported (7–10). This approach is also inappro-
priate, since 1-AG is biologically inactive.
We investigated whether the technique of liquid
chromatography tandem-mass spectrometry (LC-MS/
MS), which is substantially more specific compared
to LC-MS with a single-quadrupole mass analyzer,
would allow specific quantification of 2-AG in serum
within short analytical run times.
In a first step, we recorded collision-induced disin-
tegration mass spectra from solutions of 2-AG and
1-AG (Cayman Chemicals, Ann Arbor, MI, USA) by
direct infusion. These spectra were undistinguishable,
with a predominant fragment ion of 287 m/z. Conse-
quently, it was evident that baseline chromatographic
separation of the two compounds is mandatory to
achieve specific detection, even when applying the
highly specific LC-MS/MS technology.
We modified our previously described on-line LC-
MS/MS method for the quantification of anandamide
(11) using a longer column and a reduced proportion
of organic solvent in the analytical mobile phase (85%
methanol instead of 90%). The mass transition
379)287 was used for the detection of both 1-AG and
2-AG. Using these conditions, a single peak at a reten-
tion time of approximately 8.0 min was observed on
injection of a pure solution of 1-AG. Injection of the
2-AG standard solution showed a main peak at
approximately 7.4 min and a minor peak at approxi-
mately 8.0 min. This demonstrated contamination of
the standard solution with 1-AG. Injection of precipi-
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Figure 1 Representative LC-MS/MS chromatogram of a precipitated serum sample.
tated serum samples showed intense peaks at the
retention times for both 2-AG and 1-AG, indicating the
presence of relevant amounts of 1-AG in human
serum.
When applying the chromatographic conditions
originally used for anandamide measurement, a
single peak for the (non-specific) mass transition
379)287 was observed due to co-elution of 1-AG and
2-AG. Consequently, such an assay with a short chro-
matographic run time would be subject to isomer
interference if used for 2-AG measurement.
To study the impact of delayed processing of
serum, a freshly obtained serum sample was precip-
itated immediately and after 1 h of incubation at room
temperature for comparison. The peak area ratio
between the signals for 2-AG and 1-AG was substan-
tially different (0.7 vs. 0.2 after incubation). This dem-
onstrated that isomerization of 2-AG to 1-AG also
occurs in serum (Figure 1).
In general, our results highlight that isomers of an
individual target analyte may represent an important
source of analytical error, even when applying LC-MS/
MS with its potentially high analytical specificity.
Similar interferences can arise from in-source frag-
mentation of conjugate metabolites (12). Potential iso-
mer and metabolite interference has already been
reported for LC-MS/MS measurement of methylma-
lonic acid (13), 25-hydroxyvitamin D3 (14), and cyclo-
sporin A (15). Consequently, for specific detection of
some target analytes, rather long chromatographic
run times with appropriate separation efficacy may be
mandatory, even for LC-MS/MS.
We conclude from our observations that a short-
coming of the literature on 2-AG concentrations in
biological samples is that assay specificity towards
1-AG has not been addressed appropriately. Thus, the
results of previous studies are questionable in the
absence of statements on the method specificity with
respect to 1-AG or if summed values for active 2-AG
and inactive 1-AG have been reported. The develop-
ment of reliable MS methods for quantification of 2-
AG in the future has to consider the instability of the
target analyte in both standard materials and human
serum samples. Therefore, the impact of preanalytical
handling conditions on apparent 2-AG serum concen-
trations must be addressed carefully, as has been
done for anandamide (11). Efforts to ‘‘trap’’ 2-AG in
samples by addition of compounds interfering with its
isomerization to 1-AG might be undertaken to allow
accurate 2-AG measurement. Finally, calibration of
specific 2-AG assays has to be corrected for the
degree of analyte decay in the standard materials
used.
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